Silke Peter
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 33
-
- Antibiotic Use and Resistance 8
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 12
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research 7
- Vibrio bacteria research studies 5
- Rheumatology top 2%
-
- Genomics and Phylogenetic Studies 11
- Gut microbiota and health 10
-
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- Matthias WillmannIngo B. AutenriethMatthias MarschalPhilipp OberhettingerJan LieseWichard VogelMichael BuhlDaniela Dörfel
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Clinical Microbiology (5 papers)Journal of Antimicrobial Chemotherapy (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Silke Peter
71 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Medicine 742
- Applied Microbiology and Biotechnology 194
- Clinical Biochemistry 436
- Endocrinology 228
- Rheumatology 593
Countries citing papers authored by Silke Peter
This map shows the geographic impact of Silke Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Peter more than expected).
Fields of papers citing papers by Silke Peter
This network shows the impact of papers produced by Silke Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Peter. The network helps show where Silke Peter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Silke Peter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 26 | |
| 11 | 2020 | 62 | |
| 12 | 2019 | 104 | |
| 13 | 2017 | 61 | |
| 14 | 2016 | 3 | |
| 15 | 2015 | 49 | |
| 16 | 2015 | 72 | |
| 17 | 2014 | 19 | |
| 18 | 2014 | 9 | |
| 19 | 2003 | 81 | |
| 20 | 1999 | 24 |
About Silke Peter
Silke Peter is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 75 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Bacterial Identification and Susceptibility Testing (12 papers), Genomics and Phylogenetic Studies (11 papers), Gut microbiota and health (10 papers), Antibiotic Use and Resistance (8 papers), Enterobacteriaceae and Cronobacter Research (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Vibrio bacteria research studies (5 papers). The work is most often cited by research in Molecular Medicine (742 citations), Applied Microbiology and Biotechnology (194 citations) and Clinical Biochemistry (436 citations). Silke Peter has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Matthias Willmann, Ingo B. Autenrieth, Matthias Marschal, Philipp Oberhettinger, Jan Liese, Wichard Vogel, Michael Buhl, Daniela Dörfel, Erik C. Böttger and Reinhard Zbinden. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Frontiers in Microbiology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.